Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or BothNicholas D. James,Sarah J. Pirrie,Ann M. Pope,Darren Barton,Lazaros Andronis,Ilias Goranitis,Stuart Collins,Adam Daunton,Duncan McLaren,Joe O’Sullivan,Christopher Parker,Emilio Porfiri,John Staffurth,Andrew Stanley,James Wylie,Sharon Beesley,Alison Birtle,Janet Brown,Prabir Chakraborti,Syed Hussain,Martin Russell,Lucinda J. BillinghamJAMA Oncology（2016）引用 67|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
